Thirteen years ago, Labroots launched a new learning platform for a global scientific audience. This year, the 13th Annual Event in the Clinical Diagnostics & Research Virtual Event Series will again bring together clinicians, researchers, medical experts, and professionals to discuss the latest advances in the field. As always, Labroots aims to elevate the level of collaboration and in turn, advance clinical diagnostics, research and medicine.
On November 9, 2022, thousands will join in a discussion of the continuous progress made with advances in laboratory testing, patient care, and treatment. With new technologies and treatments available, updates in regulatory processes are also necessary to ensure patient safety and proper practices.
Call for Posters — Do you work in clinical research or diagnostics? Share your research with a virtual poster! Virtual poster sessions offer the opportunity to present your data to a global audience via a PDF poster with optional video summary and discuss the results with interested colleagues across the globe through email or our virtual networking lounge. Plan now to have your poster included in the 2022 Clinical Research & Diagnostics Virtual Event. Read about how to optimize your poster for a virtual audience here.
Submit your abstract here.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global clinical research community with a high degree of interaction through live-streaming video and chat sessions.
Continuing Education - Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.
Connect with us!
When you attend the event remember to use the hashtag #LRclinical to follow the conversation and connect with other members of the global Clinical & Molecular Dx community!
Follow @Diagnostics_LR on Twitter and @ClinicalandMolecularDiagnostics.LR on Facebook to connect with our specialist Clinical & Molecular Dx Writers and stay up to date with the latest Trending News in Clinical & Molecular Dx.
Now, you can also join our Clinical & Molecular Dx Interest Group on LinkedIn to connect with us, and the wider professional community!
Sino Biological, Inc. is a global leader in manufacturing affordable, high-quality reagents, including recombinant proteins, antibodies and cDNA clones-all in-house. We provide a one-stop shop for researchers and pharmaceutical companies around the world, helping our customers ...See more See less
ABSA International (ABSA) was founded in 1984 to promote biosafety as a scientific discipline and serve the growing needs of biosafety professionals throughout the world. Its goals are to provide a professional association that represents the interests and needs of practitioners ...See more See less
For over 30 years, Miltenyi Biotec has been a leader in the development of products that empower the advancement of biomedical research and enable cell and gene therapy. We provide innovative tools to help with your sample preparation, cell isolation, cell culture, and cell ...See more See less
DiaSorin is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics.
GenScript is the leading gene, peptide, protein and antibody research partner for fundamental life science research, translational biomedical research, and early stage pharmaceutical development. Since our establishment in 2002, GenScript has exponentially grown to become a ...See more See less
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular information. Sample technologies are used to isolate and process DNA, RNA and proteins from biological ...See more See less
Fortis Life Sciences is a strategic platform providing capital, expertise, and operational resources enabling the growth and success of founder-led life sciences tools companies. Fortis Life Sciences was founded in 2020, with the vision of creating an exceptional life sciences ...See more See less
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences ...See more See less
The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here
Suzie Alarcon CGMBS, MB(ASCP)CM is the manager of the Next Generation Sequencing Core at the La Jolla Institute for Immunology (LJI) and Team Leader of Team LJI - winner of the XPRIZE Rapid COVID Testing competition. Suzie has 18 years of experience working in molecular biology ...See more See less
Brian McNally, PhD is a Vice President at Kx Advisors and is based in Washington, DC. Brian brings his deep expertise in diagnostics and life sciences to create tailored growth strategies for his clients. He specializes in corporate strategy, product development, market sizing ...See more See less
Dr. Paul Yip is Division Head of Clinical Biochemistry at Sunnybrook Health Sciences Center in Toronto, and is Associate Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. Prior to his current position, he was at University Health ...See more See less